AVHNY vs. LLY

Last updated Jun 4, 2026

AVHNY (Ackermans & Van Haaren NV ADR) and LLY (Eli Lilly and Company) are both stocks. AVHNY operates in Engineering & Construction (Industrials), while LLY operates in Drug Manufacturers - General (Healthcare). Over the past year, AVHNY returned 68.42% vs 44.70% for LLY. At a correlation of -0.04, they often move in opposite directions.

Performance

AVHNY vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ackermans & Van Haaren NV ADR (AVHNY) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, AVHNY achieves a 2.08% return, which is significantly higher than LLY's 0.72% return.

AVHNY

• 1D: 0.00%
• 1M: 2.08%
• YTD: 2.08%
• 6M: 68.42%
• 1Y: 68.42%
• 3Y*: —
• 5Y*: —
• 10Y*: —

LLY

• 1D: 1.37%
• 1M: 11.64%
• YTD: 0.72%
• 6M: 4.73%
• 1Y: 44.70%
• 3Y*: 35.56%
• 5Y*: 41.13%
• 10Y*: 32.66%

*Multi-year figures are annualized to reflect compound growth (CAGR)

AVHNY vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024
AVHNY Ackermans & Van Haaren NV ADR	2.08%	76.45%	0.00%
LLY Eli Lilly and Company	0.72%	40.25%	-17.04%

Correlation

The correlation between AVHNY and LLY is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.05
Correlation (All Time) Calculated using the full available price history since Oct 14, 2024	-0.04

Fundamentals

Market Cap AVHNY : $8.61B LLY : $966.48B
EPS AVHNY : $3.21 LLY : $28.14
PE Ratio AVHNY : 8.20 LLY : 38.33
PEG Ratio AVHNY : 0.46 LLY : 0.77
PS Ratio AVHNY : 0.72 LLY : 13.41
PB Ratio AVHNY : 1.51 LLY : 30.98
Total Revenue (TTM) AVHNY : $11.98B LLY : $72.25B
Gross Profit (TTM) AVHNY : $3.73B LLY : $59.75B
EBITDA (TTM) AVHNY : $2.52B LLY : $32.97B

Return for Risk

AVHNY vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AVHNY

AVHNY Risk / Return Rank: 94
AVHNY Sharpe Ratio Rank: 73
AVHNY Sortino Ratio Rank: 100
AVHNY Omega Ratio Rank: 100
AVHNY Calmar Ratio Rank: 100
AVHNY Martin Ratio Rank: 99

LLY

LLY Risk / Return Rank: 72
LLY Sharpe Ratio Rank: 75
LLY Sortino Ratio Rank: 70
LLY Omega Ratio Rank: 71
LLY Calmar Ratio Rank: 73
LLY Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AVHNY vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ackermans & Van Haaren NV ADR (AVHNY) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	AVHNY	LLY	Difference
Sharpe ratio Return per unit of total volatility	1.07	1.19	-0.12
Sortino ratio Return per unit of downside risk	25.65	1.75	+23.90
Omega ratio Gain probability vs. loss probability	26.45	1.24	+25.21
Calmar ratio Return relative to maximum drawdown	26.47	1.90	+24.57
Martin ratio Return relative to average drawdown	43.70	4.73	+38.97
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

AVHNY vs. LLY - Sharpe Ratio Comparison

The current AVHNY Sharpe Ratio is 1.07, which is comparable to the LLY Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of AVHNY and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	AVHNY	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.07	1.19	-0.12
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.26	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.09	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.04	0.57	+0.47

Drawdowns

AVHNY vs. LLY - Drawdown Comparison

The maximum AVHNY drawdown since its inception was -2.64%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for AVHNY and LLY.

Drawdown Indicators

	AVHNY	LLY	Difference
Max Drawdown Largest peak-to-trough decline	-2.64%	-68.24%	+65.60%
Max Drawdown (1Y) Largest decline over 1 year	-2.64%	-23.64%	+21.00%
Max Drawdown (3Y) Largest decline over 3 years	—	-34.48%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-34.48%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-34.48%	—
Current Drawdown Current decline from peak	0.00%	-4.26%	+4.26%
Average Drawdown Average peak-to-trough decline	-0.77%	-19.22%	+18.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.59%	9.49%	-7.90%

Volatility

AVHNY vs. LLY - Volatility Comparison

The current volatility for Ackermans & Van Haaren NV ADR (AVHNY) is 2.05%, while Eli Lilly and Company (LLY) has a volatility of 9.16%. This indicates that AVHNY experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	AVHNY	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.05%	9.16%	-7.11%
Volatility (6M) Calculated over the trailing 6-month period	50.10%	26.81%	+23.29%
Volatility (1Y) Calculated over the trailing 1-year period	65.52%	37.88%	+27.64%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.03%	32.79%	+26.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.03%	30.14%	+28.89%

Dividends

AVHNY vs. LLY - Dividend Comparison

AVHNY's dividend yield for the trailing twelve months is around 3.68%, more than LLY's 0.60% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
AVHNY Ackermans & Van Haaren NV ADR	3.68%	1.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.60%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Financials

AVHNY vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Ackermans & Van Haaren NV ADR and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

AVHNY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ackermans & Van Haaren NV ADR reported a gross profit of 409.06M and revenue of 2.91B. Therefore, the gross margin over that period was 14.1%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

AVHNY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ackermans & Van Haaren NV ADR reported an operating income of 379.86M and revenue of 2.91B, resulting in an operating margin of 13.1%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

AVHNY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ackermans & Van Haaren NV ADR reported a net income of 316.94M and revenue of 2.91B, resulting in a net margin of 10.9%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.

Frequently Asked Questions

Can I hold both AVHNY and LLY in my portfolio?

AVHNY and LLY have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, AVHNY or LLY?

LLY has higher volatility (9.16%) compared to AVHNY (2.05%). In terms of maximum drawdown, AVHNY dropped -2.64% vs LLY's -68.24%.

Which has better risk-adjusted returns?

LLY currently has the higher Sharpe Ratio (1.19 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.